Ultraviolet radiation and skin aging: Roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation - A review

International Journal of Cosmetic Science

Volumn 27, Issue 1, 2005, Pages 17-34

  Pillai, Sreekumar ^a,b   Oresajo, C ^a   Hayward, J ^a  

^a Engelhard Corporation   (United States)

^b Engelhard Corporation   (United States)

Author keywords

Antipotease; Elastase; Matrix metalloprotease; Neutrophils; Serine protease

Indexed keywords

ANTIOXIDANT; CARBOHYDRATE; CATALASE; CATHEPSIN G; CELL PROTEIN; CIGARETTE SMOKE; CYTOKINE; ELASTASE; FREE RADICAL; LIPID; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RETINOID; SERINE PROTEINASE; SUNSCREEN; SUPEROXIDE DISMUTASE; THYMIDINE;

CAPILLARY PERMEABILITY; CUTANEOUS PARAMETERS; DNA DAMAGE; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; IMMUNE DEFICIENCY; NEUROENDOCRINE SYSTEM; NEUTROPHIL; OXIDATION; PHAGOCYTE; PHOTOAGING; POLLUTANT; REVIEW; SKIN CELL; SKIN INFLAMMATION; SKIN PENETRATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

EID: 14644419663     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-2494.2004.00241.x     Document Type: Review

References (124)

1. Melov, S. Mitochondrial oxidative stress: physiologic consequences and potential for a role in aging. Ann. NY Acad. Sci. 908 219-225 (2000).
2. Ashok, B.T. and Ali, R. The aging paradox: free radical theory of aging. Exp. Gerontol. 34, 293-303 (1999).
3. Wickens, A.P. Ageing and the free radical theory. Respir. Physiol. 128, 379-391 (2001).
4. Bernstein, E.F., Brown, D.B., Urback, F. et al. UV radiation activates the human elastin promoter in transgenic mice: a novel in vivo and in vitro model of cutaneous photoaging. J. Investig. Dermatol. 105, 269-273 (1995).
5. Lavker, R.M. Structural alterations in exposed and unexposed aged skin. J. Invest. Dermatol. 73, 559-566 (1979).
6. Lavker, R.M. and Kligman, A.M. Chronic heliodermatitis: a morphological evaluation of chronic actinic dermal damage with emphasis on the role of mast cells. J. Invest. Dermatol. 90, 325-330 (1988).
7. Gilchrest, B.A. Skin aging and photoaging: an overview. J. Am. Acad. Dermatol. 21, 610-613 (1989).
8. Rhie, G., Shin, M., Seo, J.Y. et al. Aging and photoaging dependent changes of enzymic and non-enzymic antioxidants in the epidermis and dermis of human skin in vivo. J. Invest. Dermatol. 117, 1212-1217 (2001).
9. Katiyar, S.K. and Mukhtar, H. Green tea polyphenol (-)-epigallocatechin- 3-gallate treatment to mouse skin prevents UVB-induced infiltration of leukocytes, depletion of antigen-presenting cells, and oxidative stress. J. Leukoc. Biol. 69, 719-726 (2001).
10. Wood, L.C., Elias, P.M., Calhoun, C. et al. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J. Invest. Dermatol. 106, 397-403 (1996).
11. Gilchrest, B.A. and Eller, M.S. DNA photodamage stimulates melanogenesis and other photoprotective responses. J. Investig. Dermatol. Syrup. Proc. 4, 35-40 (1999).
12. Gonzalez, S. and Pathak, M.A. Inhibition of UV induced formation of ROS. lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos. Photodermatol. Photoimmunol. Photomed. 12, 45-56 (1996).
13. Kawaguchi, Y., Tanaka, H., Okada, T. et al. The effects of UV A and reactive oxygen species on the mRNA expression of type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts. Arch. Dermatol. Res. 288, 39-44 (1996).
14. Takashima, A. and Bergstresser, P.R. Impact of UV radiation on the epidermal cytokine network. Photochem. Photobiol. 63, 397-400 (1996).
15. Krutmann, J. and Grewe, M. Involvement of cytokines, DNS damage and reactive oxygen intermediates in UV induced modulation of intercellular adhesion molecule-1 expression. J. Invest. Dermatol. 105 (Suppl. 1), 67S-70S (1995).
16. Bielenberg, D.R., Bucana, C.D., Sanchez, R. et al. Molecular regulation of UVB induced cutaneous angiogenesis. J. Invest. Dermatol. 111, 864-872 (1998).
17. Hruza, L.L. and Pentland, A.P. Mechanisms of UV-induced inflammation. J. Invest. Dermatol. 100, 35S-41S (1993).
18. Soter, N.A. Acute effects of UV on the skin. Semin. Dermatol. 9, 11-15 (1990).
19. Haratake, A., Uchida, Y., Mimura, K., Elias, P.M. and Holleran, W.M. Intrinsically aged epidermis displays diminished UVB-induced alterations in barrier function associated with decreased proliferation. J. Invest. Dermatol. 108, 319-323 (1997).
20. Thiele, J.J. Oxidative targets in the stratum corneum, a new basis for antioxidative strategies. Skin Pharmacol, Appl. Skin Physiol. 1, 87-91 (2001).]
21. Sander, C.S., Chang, H., Salzmann, S. et al. Photoaging is associated with protein oxidation in human skin in vivo. J. Invest. Dermatol. 118, 618-625 (2002).
22. Kang, S., Fisher, G.J. and Voorhees, J.J. Photoaging: pathogenesis, prevention, and treatment. Clin. Geriatr. Med. 17, 643-659 (2001).
23. Brenneisen, P., Sies, H. and Scharffetter-Kochanek, K. UV-B irradiation and matrix metalloproteinases: from induction via signaling to initial events. Ann. NY Acad. Sci. 973, 31-43 (2002).
24. Kupper, T.S. and Groves, R.W. The interleukin-1 axis and cutaneous inflammation. J. Investig. Dermatol. 105, 62S-66S (1995).
25. Kock, A., Schwarz, T., Kirnbauer, R. et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or UV light. J. Exp. Med. 172, 1609-1614 (1990).
26. Hirao, T., Aoki, H., Yoshida, T., Sato, Y. and Kamoda, H. Elevation of interleukin-1 receptor antagonist in the stratum corneum of sun-exposed and UV B-irradiated human skin. J. Invest. Dermatol. 106, 1102-1107 (1996).
27. Shreedhar, V., Giese, T., Sung, V.W. and Ullrich, S.E. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160, 3783-3789 (1998).
28. Brink, N., Szamel, M., Young, A.R., Wittern, K.P. and Bergemann, J. Comparative quantification of IL-1 beta, IL-10, IL-10r, TNF alpha and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflamm. Res. 49, 290-296 (2000).
29. Kondo, S. The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA-irradiation. J. Investg. Dermatol. Symp. Proc. 4, 177-183 (1999).
30. Katiyar, S.K. Skin photoprotection by green tea: antioxidant and immunomodulatory effects. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3, 234-242 (2003).
31. Schwarz, T. and Luger, T.A. Effect of UV irradiation on epidermal cell cytokine production. J. Photochem. Photobiol. B 4, 1-13 (1989).
32. Luger, T.A., Scholzen, T. and Grabbe, S. The role of alpha melanocyte stimulating hormone in cutaneous biology. J. Investig. Dermatol. Symp. Proc. 2, 87-93 (1997).
33. Mildner, M., Weninger, W., Trautinger, F., Ban, J. and Tschachler, E. UVA and UVB radiation differentially regulate vascular endothelial growth factor expression in keratinocyte-derived cell lines and in human keratinocytes. Photochem. Photobiol. 70, 674-679 (1999).
34. Lee, S.C., Lee, J.W., Jung, J.E. et al. Protective role of nitric oxide-mediated inflammatory response against lipid peroxidation in UVB-irradiated skin. Br. J. Dermatol. 142, 653-659 (2000).
35. Seo, S.J., Choi, H.G., Chung, H.J. and Hong, C.K. Time course of expression of mRNA of inducible nitric oxide synthase and generation of nitric oxide by UV B in keratinocytes cell lines. Br. J. Dermatol. 147, 655-662 (2002).
36. Gilchrest, B.A., Park. H.Y., Eller, M.S. and Yarr, M. Mechanisms of UV induced pigmentation. Photochem. Photobiol. 63, 1-10 (1996).
37. Suh, D.H., Kwon, T.E. and Youn, J.I. Changes of comedonal cytokines and sebum secretion after UV irradiation in acne patients. Eur. J. Dermatol. 12, 139-144 (2002).
38. Trenum, C.W., Blake, D.R. and Morris, C.J. Skin inflammation: reactive oxygen species and the role of iron. J. Invest. Dermatol. 99, 675-682 (1992).
39. Chlopicki, S., Olszanecki, R., Janiszewski, M. et al. Antioxid. Redox Signal. 6, 691-698 (2004).
40. Abeyama, K., Eng, W., Jester, J.V. et al. A role for NF-kappa B dependent gene transactivation in sunburn. J. Clin. Invest. 105, 1751-1759 (2000).
41. Rittie, L. and Fisher, G.J. UV-light-induced signal cascades and skin aging. Ageing Res Rev. 1, 705-720 (2002).
42. Krishnadasan, B., Naidu, B.V., Byrne, K. et al. The role of proinflammatory cytokines in lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 125, 261-272 (2003).
43. Hales, J.M. and Camp, R.D. Potent T cell stimulatory material with antigenic properties in stratum corneum of normal human skin. J. Invest. Dermatol. 110, 725-729 (1998).
44. Tanaka, N., Fujioka, A., Tajima, S., Ishibashi, A. and Hirose, S. Elafin is induced in epidermis in skin disorders with dermal neutrophilic infiltration: interleukin-1 beta and tumor necrosis factor-alpha stimulate its secretion in vitro. Br. J. Dermatol. 143, 728-732 (2000).
45. Drew, B. and Leeuwenburgh, C. Aging and the role of reactive nitrogen species. Ann. NY Acad. Sci. 959, 66-81 (2002).
46. Weissmann, G., Smolen, J.E. and Hoffstein, S. Polymorphonuclear leukocytes as secretory organs of inflammation. J. Investig. Dermatol. 71, 95-99 (1978).
47. Pol, A., Pfundt, R., Zeeuwen, P., Molhuizen, H. and Schalkwijk, J. Transcriptional regulation of the elafin gene in human keratinocytes. J. Invest. Dermatol. 120, 301-307 (2003).
48. Nakane, H., Ishida-Yamamoto, A., Takashashi, H. and Ilzuka, H. Elafin, a secretory protein, is cross-linked into the cornified cell envelopes from the inside of psoriatic keratinocytes. J. Invest. Dermatol. 119, 50-55 (2002).
49. Simon, S.R., Roemer, E.J., Golub, L.M. and Ramamurthy, N.S. Serine proteinase inhibitory activity by hydrophobic tetracycline. US Patent no. 5773430 (1998).
50. Rogalski, C., Ulf, M.-H., Proksch, E. and Wiedow, O. Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J. Invest. Dermatol. 118, 49-54 (2002).
51. Piskin, G., Tursen, U., Bos, J.D. and Teunissen, M.B. IL-4 expression by neutrophils in psoriasis lesional skin upon high-dose UVB exposure. Dermatology 207, 51-53 (2003).
52. Schaerli, P., Britschgi, M., Keller, M. et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J. Immunol. 173, 2151-2158 (2004).
53. Meyer-Hoffert, U., Wingertszahn, J. and Wiedow, O. Human leukocyte elastase induces keratinocyte proliferation by epidermal growth factor receptor activation. J. Investig. Dermatol. 123, 338-345 (2004).
54. Starcher, B., O'Neal, P., Granstein, R.D. and Beissert, S. Inhibition of neutrophil elastase suppresses the development of skin tumors in hairless mice. J. Invest. Dermatol. 107, 159-163 (1996).
55. Tsukahara, K., Takema, Y., Moriwaki, S. et al. Selective inhibition of skin fibroblast elastase elicits a concentration-dependent prevention of UV B-induced wrinkle formation. J. Invest. Dermatol. 117, 671-677 (2001).
56. Mallya, S.A., Hall, J.E., Lee, H.M. et al. Interaction of matrix metalloproteinases with serine protease inhibitors. Ann. NY Acad. Sci. 732, 303-314 (1994).
57. Rinehart, A.R., Mallya, S., Simon, S.R. et al. Human alpha-proteinase inhibitor binds to extracellular matrix in vitro. Am. J. Respir. Cell Mol. Biol. 9, 666-679 (1993).
58. Henry, M.T., McMahon, K., Costello, C., Fitzgerald, M.X. and O'Connor, C.M. Secretory leukocyte proteinase inhibitor and elafin are resistant to degradation by MMP-8. Exp. Lung Res. 28, 85-97 (2002).
59. Zhang, Y., DeWitt, D.L., McNeely, T.B., Wahl, S.M. and Wahl, L.M. Secretory leukocyte protease inhibitor suppresses the production of monocyte PGH synthase-2, PGE2 and MMPases. J. Clin. Invest. 99, 894-900 (1997).
60. Kahari, V.M. and Saarialho-Kere, U. Matrix metalloproteinases in skin. Exp. Dermatol. 6, 199-213 (1997).
61. Brennan, M., Bhatti, H., Nerusu, K.C. et al. Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem. Photobiol. 78, 43-48 (2003).
62. Fisher, G.J., Choi, H.C., Bata-Csorgo, Z. et al. UV irradiation increases matrix metalloproteinase-8 protein in human skin in vivo. J. Invest. Dermatol. 117, 219-226 (2001).
63. Fisher, G.J., Datta, S.C., Talwar, H.S. et al. Molecular basis of sun-induced premature skin ageing and retinoic antagonism. Nature 379, 335-339 (1996).
64. Ashcroft, G.S., Herrick, S.E., Tarnuzzer, R.W. et al. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA. J. Pathol. 183, 169-176 (1997).
65. Scharffetter, K., Wiaschek, M., Hogg, A. et al. UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Arch. Dermatol. Res. 283, 506-511 (1991).
66. Herrmann, G., Wlasehek, M., Lange, T.S. et al. UVA irradiation stimulates the synthesis of various matrix metalloproteinases in cultured human fibroblasts. Exp. Dermatol. 2, 92-97 (1993).
67. Petersen, M.J., Hansen, C. and Craig, S. Ultraviolet A irradiation stimulates collagenase production in cultured human fibroblasts. J. Invest. Dermatol. 99, 440-444 (1992).
68. Mauviel, A. Cytokine regulation of metalloproteinase gene expression. J. Cell Biochem. 53, 288-295 (1993).
69. Van Wart, H.E. and Birkedal-Hansen, H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl Acad. Sci. USA 87, 5578-5582 (1990).
70. Birkedal-Hansen, H. Moore, W.G.L. Bodden, M.K. et al. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4. 197-250 (1993).
71. Watson, S.A. and Tierney, G. Matrix metalloproteinase inhibitors: a review. BioDrugs 9, 325-335 (1998).
72. Scholzen, T.E., Brzoska, T., Kalden, D.H. et al. Effect of UV light on the release of neuropeptides and neuroendocrine hormones in the skin; mediators of photodermatitis and cutaneous inflammation. J. Investig. Dermatol. Symp. Proc. 4, 55-60 (1999).
73. Eller, M.S., Ostrom, K. and Gilchrest, B.A. DNA damage enhances melanogenesis. Proc. Natl Acad. Sci. USA 93, 1087-1092 (1996).
74. Eller, M.S., Maeda, T., Magnoni, C., Atwal, D. and Gilchrest, B.A. Enhancement of DNA repair in human skin cells by thymidine dinucleotides: evidence for a p53-mediated mammalian SOS response. Proc. Natl Acad. Sci. USA 94, 12627-12632 (1997).
75. Wu, C., Marks, S., Prk, H.Y., Howard, C. and Gilchrest, B.A. T-oligos induce mitf, tyrosinase and pkc-beta in cultured human melanocytes. Pigment Cell Res. 17, 452 (2004).
76. Seite, S., Colige, A., Piquemal-Vivenot, P. et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol. Photoimmunol. Photomed. 16, 147-155 (2000).
77. Thiele, J.J. Photoaging is associated with protein oxidation in human skin in vivo. J. Invest. Dermatol. 118, 618-625 (2002).
78. Weber, S.U., Thiele, J.J., Cross, C.E. and Packer, L. Vitamin C. uric acid, and glutathione gradients in murine stratum corneum and their susceptibility to ozone exposure. J. Invest. Dermatol. 113, 1128-1132 (1999).
79. Hellemans, L., Corstjens, H., Neven, A., Declercq, L. and Maes, D. Antioxidant enzyme sactivity in human stratum corneum shows seasonal variation with an age-dependent recovery. J. Invest. Dermatol. 120, 434-439 (2003).
80. Dreher, F. and Maibach, H. Protective effects of topical antioxidants in humans. Curr. Probl. Dermatol. 29, 157-164 (2001).
81. Podda, M. and Grundmann-Kollmann, M. Low molecular weight antioxidants and their role in skin ageing. Clin. Exp. Dermatol. 26, 578-582 (2001).
82. Skaper, S.D., Fabris, M., Ferrari, V., Dalle Carbonare, M. and Leon, A. Querectin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Radic. Biol. Med. 22, 669-678 (1997).
83. Katiyar, S.K., Afaq, F., Perez, A. and Mukhtar, H. polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits UV radiation-induced oxidative stress. Carcinogenesis 22, 287-294 (2001).
84. Vayalil, P.K., Elmets, C.A. and Katiyar, S.K. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 24, 927-936 (2003).
85. Zhao, J., Wang, J., Chen, Y. and Agarwal, R. Anti-tumor-promoting activity of a polyphenolic fraction isolated from grape seeds in the mouse skin two-stage initiation-promotion protocol and identification of procyanidin B5-3′-gallate as the most effective antioxidant constituent. Carcinogenesis 20, 1737-1745 (1999).
86. Afaq, E., Saleem, M., Brans, R. and Mukhtar, H. Novel agents and targets for skin cancer chemoprevention: studies with pomegranate fruit extract. J. Investig. Dermatol. 121 (2003) (abstract no. 140).
87. Phillipson, J.D. 50 years of medicinal plant research - every progress in methodology is a progress in science. Planta Med. 69, 491-495 (2003).
88. Russo, A., Izzo, A.A., Cardile, V., Borrelli, F. and Vanella, A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 8, 125-132 (2001).
89. Svobodova, A., Psotova, J. and Walterova, D. Natural phenolics in the prevention of UV-induced skin damage: a review. Biomed. Pap. 147, 137-145 (2003).
90. Bissett, D.L., Chatterjee, R. and Hannon, D.P. Photoprotective effect of topical anti-inflammatory agents against UV radiation-induced chronic skin damage in the hairless mouse. Photodermatol. Photoimmunol. Photomed. 7, 153-158 (1990).
91. Kang, I.C., Kim, S.A., Song, G.Y. et al. Effects of the ethyl acetate fraction of Spatholobi caulis on tumor cell aggression and migration. Phytother. Res. 17, 163-167 (2003).
92. Thacher, S.M., Vasudevan, J., Tsang, K.Y., Nagpal, S. and Chandraratna, R.A. New dermatological agents for the treatment of psoriasis. J. Med. Chem. 44, 281-297 (2001).
93. Verschoore, M., Bouclier, M., Czernielewski, J. and Hensby, C. Topical retinoids, their uses in dermatology. Dermatol. Clin. 11, 107-115 (1993).
94. Guenther, L.C. Topical tazarotene therapy for psoriasis, acne and photoaging. Skin Therapy Lett. 7, 1-4 (2002).
95. Griffiths, C.E. Retinoids and vitamin D analogues: action on nuclear transcription. Hosp. Med. 59, 12-16 (1998).
96. Gupta, A.K. and Chow, M. Pimecrolimus: a review. J. Eur. Acad. Dermatol. Venereol. 17, 493-503 (2003).
97. Niedner, R. Topical corticosteroids versus topical inhibitors of calcineurin. Hautarzt 54, 338-341 (2001).
98. Voorhees, J.J. and Fisher, G.J. Method of inhibiting photoaging of skin. US Patent no. 5837224 (1998).
99. Fisher, G.J., Voorhees, J.J. and Kang, S. Compositions and methods for inhibiting photoaging of skin. US Patent no. 6365630 (2002).
100. Varani, J., Fisher, G.J., Voorhees, J.J. and Kang, S. Methods and compositions for preventing and treating chronological aging in human skin. US Patent application no. 20010053347 (2001).
101. Fisher, G.J., Talwar, H.S., Lin, J. and Voorhees, J.J. Molecular mechanisms of photoaging in human skin in vivo and their prevention by all-trans retinoic acid. Photochem. Photobiol. 69, 154-157 (1999).
102. Mauviel, A., Halcin, C., Vasiloudes, P., Prks, W.C., Kurkinen, M. and Uitto, J. Unco-ordinate regulation of collagenase, stromelysin and TIMP genes by PGE2: selective enhancement of collagenase gene expression in human dermal fibroblasts in culture. J. Cell Biochem. 54, 465-472 (1994).
103. Varani, J., Fisher, G.J. and Voorhees, J.J. Method for protecting and restoring skin using selective MMP inhibitors. US Patent application no. 20020119107 (2002).
104. Pentapharm news release. IFSCC news release from Phenta pharm at http://www.pentapharm.com on PEPHA-TIMP, a product to inhibit MMP and stimulate collagen synthesis.
105. Hantke, B., Lahmann, C., Venzke, K. et al. Influence of flavonoids and vitamins on the MMP- and TIMP-expression of human dermal fibroblasts after UVA irradiation. Photochem. Photobiol. Sci. 1, 826-833 (2002).
106. Stab, F. and Tschesche, H. Influence of flavonoids and vitamins on the MMP- and TIMP-expression of human dermal fibroblasts after UVA irradiation. Photochem. Photobiol. Sci. 1, 826-833 (2002).
107. Kut-Lasserre, C., Miller, C.C., Ejeil, A.L. et al. Effect of avocado and soybean unsaponifiables on gelatinase A (MMP-2), stromelysin 1 (MMP-3), and tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) secretion by human fibroblasts in culture. J. Periodontol. 72, 1685-1694 (2001).
108. Demeule, M., Brossard, M., Page, M., Gingras, D. and Beliveau, R. Matrix metalloproteinase inhibition by green tea catechins. Biochim. Biophys. Acta 1478, 51-60 (2000).
109. Morrow, D.M., Fitzsimmons, P.E., Chopra, M. and McGlynn, H. Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat. Res. 1, 480-481 (2001).
110. Song, L., Xu, M., Lopes-Virella, M.F. and Huang, Y. Quercetin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells through extracellular signal-regulated kinase. Arch. Biochem. Biophys. 391, 72-78 (2001).
111. Sato, T., Koike, L., Miyata, Y. et al. Inhibnition of AP-1binding activity and PIP-3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of TIMP-1 production and suppression of production of MMP-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 62, 1025-1029 (2002).
112. Isnard, N., Peterszegi, G., Robert, A.M. and Robert, L. Regulation of elastase type endoprptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and fucuse-rich polysaccharide. Biomed. Pharmacother. 56, 258-264 (2002).
113. Cha, B.Y., Bpark, C.J., Lee, D.G. et al. Inhibitory effect of methanol extract of Euonymus alatus on MMP-9. J. Ethanopharmacol. 85, 1637 (2003).
114. Sun, Y. and Xu, Q. Aqueous extract from Rhizoma notopterygii reduces conteact sensitivity by inhibiting lymphocyte migrationvia down-regulating MMP activity. Pharmacol. Res. 46, 333-337 (2002).
115. Rothenberg, M.L., Nelson, A.R. and Hande, K.R. New drugs on the horizon: matrix metalloproteinase inhibitors. Oncologist 3, 271-274 (1998).
116. Holleran, W.M., Galardy, R.E., Gao, W.N. et al. Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia. Arch. Dermatol. Res. 289, 138-144 (1997).
117. Yamamoto, M., Tsujishita, H., Hori, N. et al. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket. J. Med. Chem. 41, 1209-1217 (1998).
118. Brown, P.D. Ongoing trials with matrix metalloproteinase inhibitors. Exp. Opin. Investig. Drugs 9, 2167-2177 (2000).
119. Ying, Q.L., Rinehart, A.R., Simo, S.R. and Cheronis, J.C. Inhibition of human leucocyte elastase by ursolic acid: evidence for a binding site for pentacyclic triterpenes. Biochem. J. 277, 521-526 (1991).
120. Sartor, L., Pezzato, E. and Garbisa, S. (-)Epigallo-catechin-3-gallate inhibits leukocyte elastase: potential of the phyto-factor in hindering inflammation, emphysema, and invasion. J. Leukoc. Biol. 71, 73-79 (2002).
121. Simon, S., Vered, M., Rinehart. A., Cheronis, J. and Janoff, A. Inhibition of human neutrophil elastase by polyguanylic acid and other synthetic polynucleotides. Adv. Exp. Med. Biol. 240, 65-74 (1988).
122. Tyagi, S. and Simon, S.R. Parinaric acids as probes of binding domains in neutrophil elastase. J. Biol. Chem. 266, 15185-15191 (1991).
123. Tyagi, S. and Simon, S.R. Inhibitors directed to binding domains in neutrophil elastase. Biochemistry 20, 9970-9977 (1990).
124. Tyagi, S. and Simon, S.R. Interaction of neutrophil elastase with hydrophobic polyanoinic chelators. Biochem. Cell Biol. 69, 624-629 (1991b).